Current neoadjuvant treatment options for HER2-positive breast cancer.
about
Exosomal Proteome Profiling: A Potential Multi-Marker Cellular Phenotyping Tool to Characterize Hypoxia-Induced Radiation Resistance in Breast Cancer.Exosomes as divine messengers: are they the Hermes of modern molecular oncology?Exosome removal as a therapeutic adjuvant in cancer.Systemic treatment in breast cancer: a primer for radiologistsUltrasonography-guided surgical clip placement for tumor localization in patients undergoing neoadjuvant chemotherapy for breast cancer.
P2860
Current neoadjuvant treatment options for HER2-positive breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Current neoadjuvant treatment options for HER2-positive breast cancer.
@ast
Current neoadjuvant treatment options for HER2-positive breast cancer.
@en
type
label
Current neoadjuvant treatment options for HER2-positive breast cancer.
@ast
Current neoadjuvant treatment options for HER2-positive breast cancer.
@en
prefLabel
Current neoadjuvant treatment options for HER2-positive breast cancer.
@ast
Current neoadjuvant treatment options for HER2-positive breast cancer.
@en
P2860
P356
P1476
Current neoadjuvant treatment options for HER2-positive breast cancer.
@en
P2093
Hikmat Abdel-Razeq
Lina Marei
P2860
P356
10.2147/BTT.S22917
P577
2011-08-09T00:00:00Z